fenofibrate + vitamin E

Fenofibrate + vitamin E is a fixed-dose combination of two agents used primarily for their complementary effects on lipid metabolism and oxidative stress. Fenofibrate is a fibrate class drug that acts as an agonist of peroxisome proliferator activated receptor alpha (PPARα), leading to increased lipolysis, reduced triglycerides, decreased LDL cholesterol, and increased HDL cholesterol. Vitamin E (alpha-tocopherol) is a fat-soluble antioxidant that protects cell membranes from oxidative damage by neutralizing free radicals. The combination has been studied for its potential synergistic effect in increasing resistance of non-HDL lipoproteins to oxidation and improving lipid profiles in patients with dyslipidemia or diabetes[1][3]. This combination may be formulated as co-micronized particles for enhanced bioavailability[3].